Showing results (801-810 of 19,461) with videos related to
Sort By:
Pageof 1,947
Lancet (London, England)|February 3, 2012
Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort studyRobert Kraft, David N Herndon, Ahmed M Al-Mousawi, et al.Lancet (London, England)|February 10, 2012
Management of infective endocarditis: challenges and perspectivesFranck Thuny, Dominique Grisoli, Frederic Collart, et al.Lancet (London, England)|April 2, 2013
Migration and health in an increasingly diverse EuropeBernd Rechel, Philipa Mladovsky, David Ingleby, et al.Lancet (London, England)|June 4, 2013
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistanceYunwen Hu, Shuihua Lu, Zhigang Song, et al.Lancet (London, England)|June 4, 2013
Evolving importance of kidney disease: from subspecialty to global health burdenKai-Uwe Eckardt, Josef Coresh, Olivier Devuyst, et al.Lancet (London, England)|May 15, 2013
Controversies in primary treatment of low-risk papillary thyroid cancerDonald S A McLeod, Anna M Sawka, David S CooperLancet (London, England)|June 13, 2013
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association studyMinoli A Perera, Larisa H Cavallari, Nita A Limdi, et al.Lancet (London, England)|June 18, 2013
Prevalence of abuse and intimate partner violence surgical evaluation (PRAISE) in orthopaedic fracture clinics: a multinational prevalence study, Sheila Sprague, Mohit Bhandari, et al.Lancet (London, England)|April 26, 2013
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cyclesDavid Cunningham, Eliza A Hawkes, Andrew Jack, et al.Pageof 1,947